Rtw Investments, LP Clearside Biomedical, Inc. Transaction History

Rtw Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $5.14 Million - $11 Million	-3,806,018 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $1.09 Million - $2.29 Million	-400,747 Reduced 9.53%	3,806,018 $10.5 Million
Q1 2021 May 14, 2021	BUY	$2.24 - $4.25 $556,942 - $1.06 Million	248,635 Added 6.28%	4,206,765 $10.4 Million
Q4 2020 Feb 16, 2021	BUY	$1.32 - $2.74 $14,007 - $29,076	10,612 Added 0.27%	3,958,130 $10.8 Million
Q3 2020 Nov 16, 2020	BUY	$1.45 - $2.0 $43,349 - $59,792	29,896 Added 0.76%	3,947,518 $6.08 Million
Q2 2020 Aug 14, 2020	BUY	$1.55 - $2.41 $52,904 - $82,258	34,132 Added 0.88%	3,917,622 $7.37 Million
Q1 2020 May 15, 2020	BUY	$1.32 - $3.77 $176,065 - $502,853	133,383 Added 3.56%	3,883,490 $6.6 Million
Q4 2019 Feb 14, 2020	BUY	$0.62 - $3.4 $1,492 - $8,187	2,408 Added 0.06%	3,750,107 $10.9 Million
Q3 2019 Nov 14, 2019	BUY	$0.59 - $1.32 $2.21 Million - $4.95 Million	3,747,699 New	3,747,699 $2.36 Million

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.